Clinical TrialsSearch results
Number of results: 281
Other
- Randomized clinical trial about the period of antimicrobial prophylaxis administration in hepatocellular carcinoma surgery
- Patients undergoing elective hepatocellular carcinoma surgery
- Randomized clinical trial committee, Japan Society for Surgical Infection
- 2009-12-09
Other
- Randomised controlled trial of multiple drugs combined therapy for diffuse IgA nephropathy
- Refractory IgA nephropathy
- Japanese Study Group of Multiple drug therapy for IgAN
- 2006-03-31
Other
- Randomiazed controlled trial comparing docetaxel-cisplatin combination with docetaxel alone in elderly patients with advanced non-small-cell lung cancer(JCOG0803/WJOG4307L)
- non-small-cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2008-10-10
Other
- Randmized controlled trial to test set-therapy and individualized-therapy for elderly acute myelocytic leukemia
- acute myelocytic leukemia
- Japan Adult Leukemia Study Group
- 2005-09-20
Recruiting
- RA-BE-LEAVE study
- Rheumatoid arthritis
- Miyazaki Yusuke
- 2023-02-13
Other
- Prospective, randomized, open-label, blinded-endpoint trial to examine the effect of active vitamin D on cardiovascular events in hemodialysis patients: Japan Dialysis Active Vitamin D trial (J-DAVID)
- Chronic kidney disease stage 5D
- J-DAVID Research Group
- 2008-06-19
Other
- Prospective study of the severity-based treatment protocol for Japanese patients with MPO-ANCA-associated vasculitis
- MPO-ANCA-associated vasculitis
- Research Committe of Intractable Vasculitis Syndrome of the Ministry of Health, Labor and Welfare of Japan
- 2007-10-30
Other
- Prospective Ramdomized Trial of Extracranial-intracranial (EC-IC) Bypass Surgery for Adults with Moyamoya Disease with Hemorrhagic Onset
- Moyamoya disease
- JAM Trial executive and steering committee
- 2005-09-13
Other
- Prospective Observational Survey on the Long-Term Effects of the LDL-Apheresis on the Drug Resistant Nephrotic Syndrome
- Refractory (drug resistant) nephrotic syndrome
- the Japanese Society of Kidney and Lipids Research
- 2007-11-01
Other
- Primary prevention of cerebrovascular and cardiovascular events with an oral antidiabetic agent in patients with type 2 diabetes at high risk for cerebral infarction
- Type 2 Diabetes
- PROFIT-J Study Steering Committee
- 2007-10-09